J&J posts weak medical device sales, shares fall
By Michael Erman and Sriparna Roy Oct 13 (Reuters) - Johnson & Johnson reported sales in its medical devices business on Tuesday that fell short of Wall Street expectations, citing geopolitical issues including the Middle East conflict, and its shares fell more than 6%.